Recruiting Scleroderma Studies in Columbia
About Scleroderma Clinical Trials in Columbia
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 1 scleroderma clinical trials recruiting participants in Columbia, MO. These studies are seeking a combined 81 participants. Research is being sponsored by argenx. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Columbia — FAQ
Are there scleroderma clinical trials in Columbia?
Yes, there are 1 scleroderma clinical trials currently recruiting in Columbia, MO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbia research site will contact you about next steps.
Are clinical trials in Columbia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbia studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 1 active trials in Columbia are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated March 2, 2026 from ClinicalTrials.gov